European Cannabis Holdings (ECH), Grow Biotech, and IPS Specials have imported the first bulk shipment of cannabis-based medicine to the UK, since the Home Office legalised medical cannabis in November. "The landmark moment for the UK’s fledgling medical cannabis industry will greatly improve access for patients.", the companies say.
The three firms worked in close collaboration to import the shipment, which was exported by the Office of Medical Cannabis of the Netherlands, and will be distributed to patients via a pharmacy in the UK. The shipment includes Bedrocan Flower Afina, and Bedica Flower Talea, which are used to treat a range of conditions including chronic pain and multiple sclerosis. "The shipment also contains additional supply that will ensure continuity for patients.", the companies points out.
“The first shipment of medical cannabis arriving in the UK is a break-through moment for improving access to treatments for a range of serious illnesses. The fact that we are now in a position to write prescriptions that can actually be fulfilled is a huge achievement. Patients no longer need to worry about how they can access their medication, which will mark a positive step change in their journey and finally provide the relief that they are looking for, and we can now finally provide.” says Dr. David McDowell, a member of ECH’s medical board.
Stephen Murphy, group managing director, and co-founder of ECH says: “The legalisation of prescription cannabis has given people with chronic illnesses hope and now, availability of medical cannabis, increased data and better education services for healthcare professionals will improve access rates and drive down cost.”